Depending on where the mutation is located it can change the surface of a protein and therefore change the interaction with partner molecules or ligands. Protein-protein interaction can be affect positively or negatively.
Many mutations also affect the mRNA by introducing or removing splice sites (15% of clinically important mutations) or by affecting its synthesis, translation or degradation. Introduction of stop-codons has also been observed.